Top takeaways from Q1FY17 : Revenue growth was lower than our/street estimates due to lower-than-expected volume growth and sluggish growth in Personal Care Margins continued to see expansion because of lower input prices of key raw materials.The stock currently trades at 39x FY18 earnings; with expected earnings CAGR of just 12% in FY16-19, Phillip Capital see the stock de-rating to 36x FY18 earnings over the next year,they value the stock at Rs 830 (previously Rs 765) and maintain Sell.Trendlyne has 21 reports on HINDUNILVR updated in the last year from 6 brokers with an average target of Rs 866.2. Brokers have a rating for HINDUNILVR with 2 price upgrades in past 6 months and 2 downgrades,4 price downgrades,1 upgrades and 6 price upgrades in past 1 Year.